Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 okt 2013 - 07:44
Statutaire naam
Galapagos NV
Titel
Galapagos to present GLPG0634 at ACR
Bericht
Mechelen, Belgium; 16 October 2013 - Galapagos NV (Euronext: GLPG) announced today that the Company will present data on the pharmacodynamics and efficacy of its selective JAK1 inhibitor GLPG0634 at the ACR (American College of Rheumatology) which will take place from 25-30 October 2013 in San Diego, CA, US. The abstracts are now available online on the ACR website.
Datum laatste update: 25 december 2025